Myriad Genetics Inc (NASDAQ:MYGN)

29.94
Delayed Data
As of Jun 15
 0.00 / 0.00%
Today’s Change
10.54
Today|||52-Week Range
33.97
+51.40%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 28.00, with a high estimate of 37.00 and a low estimate of 15.00. The median estimate represents a -6.48% decrease from the last price of 29.94.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$162.7M
Reporting Date
Sep 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -70.37%
 
 
 
 
 
 
Growthannually -166.67%
 
 
 
 
 
 

Sales

Growthquarterly -6.01%
 
 
 
 
 
 
Growthannually 4.53%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.